Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 10
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
7/1/1992
1.
Phase I/II Study of CTX/VCR/DOX/VP-16 with ddI, G-CSF, and CNS Prophylaxis/Therapy in Patients with AIDS-Associated non-Hodgkin's Lymphoma (Summary Last Modified 07/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Completed
18 and over
NCI
NCI-92-C-0162
NCI-T92-0039N, T92-0039
Last Modified:
9/1/1993
2.
Phase I/II Study of ABV (DOX/BLEO/VCR) and ddI or ddC in Patients with Advanced AIDS-Related Kaposi's Sarcoma (Summary Last Modified 09/93)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
over 12
NIAID
NIAID-ACTG-163
Last Modified:
11/1/1994
3.
Phase II Pilot Study of CDE (CTX/DOX/VP-16) and G-CSF plus ddI for HIV-Related Intermediate- and High-Grade non-Hodgkin's Lymphoma (Summary Last Modified 11/94)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
AECM-9312379
NCI-V94-0439
Last Modified:
11/12/2008
4.
Phase II Study of CDE (CTX/DOX/VP-16) plus ddI for HIV-Related Intermediate- and High-Grade non-Hodgkin's Lymphoma (Summary Last Modified 08/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
E-1494
E1494
Last Modified:
12/1/2000
5.
Phase II Study of Etoposide/Mitoxantrone/Prednimustine for Relapsed Disease and Cyclophosphamide/Doxorubicin/Etoposide for Refractory Disease in Patients with HIV-Associated non-Hodgkin's Lymphoma (Summary Last Modified 12/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
ITA-GICAT-C/941202-3
EU-96059, NCT00002905
Last Modified:
1/1/1998
6.
Phase II Pilot Study of Epirubicin/Bleomycin/Vinblastine/Prednisone with G-CSF and Either Zidovudine or Didanosine in HIV-Associated Hodgkin's Disease (Summary Last Modified 01/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 15
ITA-GICAT-C/890301
EU-96054
Last Modified:
2/1/1992
7.
Phase II Pilot Study of TRA and Antiretroviral Therapy in HIV-Related Kaposi's Sarcoma (Summary Last Modified 02/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
over 18 to less than 70
NCI
LAC-USC-17K911
NCI-T91-0126D, T91-0126
Last Modified:
3/1/2001
8.
Phase II Pilot Study of Chemotherapy in Children and Adolescents with non-Hodgkin's Lymphoma and Lymphoproliferative Disorders Associated with Congenital or Acquired Immunodeficiency Syndromes (Summary Last Modified 03/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
3 months to 18 years
NCI
NCI-93-C-0207B
NCI-T93-0006N, T93-0006
Last Modified:
6/1/1995
9.
Phase I Study of Genetically Modified CD8+ HIV-Specific T Cells for HIV-Seropositive Patients Undergoing Allogeneic Bone Marrow or Syngeneic T-Cell-Depleted PBSC Transplantation (Summary Last Modified 06/95)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 to 45
NCI
FHCRC-696.2
NCI-H94-0411
Last Modified:
3/1/1999
10.
Phase I Study of Cellular Adoptive Immunotherapy with Epstein-Barr Virus (EBV)-Specific Cytotoxic T-Cells Following Chemotherapy for Refractory or Recurrent EBV-Expressing, HIV-Associated, Intermediate-or High-Grade B-Cell non-Hodgkin's Lymphoma (Summary Last Modified 03/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 to 45
NCI
DUMC-BB-IND-5464
NCI-V97-1123
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute